OrthoPediatrics Corp. (KIDS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol KIDS
- Company OrthoPediatrics Corp.
- Price $30.8
- Changes Percentage 29.3
- Change 6.98
- Day Low $24.79
- Day High $31.51
- Year High $26.74
- Year Low $14.42
- Market Cap $581,508,264
- Price Avg 50 EMA (D) $22.35
- Price Avg 200 EMA (D) $18.81
- Exchange NASDAQ
- Volume 105,866
- Average Volume 212,707
- Open $24.94
- Previous Close $23.82
- EPS -1.18
- PE -19.19
- Earnings Announcement 2026-10-27 04:00:00
- Shares Outstanding $25,684,994
Company brief: ORTHOPEDIATRICS CORP. (KIDS )
- Healthcare
- Medical - Devices
- Mr. David R. Bailey
- https://www.orthopediatrics.com
- US
- N/A
- 10-13-2017
- US68752L1008
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
KIDS Corporation News
OrthoPediatrics: 3 Key Takeaways for Long-Term Investors
fool.com -- OrthoPediatrics raised 2026 revenue guidance to $270 million to $273 million. Third-quarter revenue grew 19% year over year to $72.7 million....
OrthoPediatrics Q3 Earnings Call Highlights
marketbeat.com -- OrthoPediatrics NASDAQ: KIDS reported record third-quarter revenue and raised its full-year sales outlook, citing broad-based demand across its trauma, deformity, scoliosis and specialty bracing busin...